1 not yet recruiting. .
Follow Vida Fertility Institute: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Linzagolix in Adenomyosis and Recurrent Implantation Failure Linzagolix 200 mg (Yselty) - Adenomyosis of Uterus, Implantation Failure | Not yet recruiting | Vida Fertility Institute | 30 | 2027-01-01 | 2026-10-21 |
Adenomyosis (1) · Infertility, Female (1)
linzagolix (1)
Spain (1)